应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
00503 朗生医药
停牌 12-18 09:20:11
1.790
+0.000
0.00%
最高
1.790
最低
1.790
成交量
0.00
今开
1.790
昨收
1.790
日振幅
0.00%
总市值
7.51亿
流通市值
7.51亿
总股本
4.19亿
成交额
0.00
换手率
0.00%
流通股本
4.19亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
朗生医药:预期将于12月19日撤销上市地位
新浪港股 · 2023-12-18
朗生医药:预期将于12月19日撤销上市地位
朗生医药(00503):预期将于12月19日撤销上市地位
智通财经网 · 2023-12-18
朗生医药(00503):预期将于12月19日撤销上市地位
朗生医药将于12月19日起被撤销股份于联交所主板的上市地位
新浪港股 · 2023-12-15
朗生医药将于12月19日起被撤销股份于联交所主板的上市地位
朗生医药(00503)将于12月19日起被撤销股份于联交所主板的上市地位
智通财经网 · 2023-12-15
朗生医药(00503)将于12月19日起被撤销股份于联交所主板的上市地位
港股收盘(11.28) | 恒指收跌0.98% 苹果概念股逆势走强 瑞声科技(02018)收涨逾7%
智通财经 · 2023-11-28
港股收盘(11.28) | 恒指收跌0.98% 苹果概念股逆势走强 瑞声科技(02018)收涨逾7%
朗生医药股价拉升40.16% 市值涨3亿港元
自选股智能写手 · 2023-11-28
朗生医药股价拉升40.16% 市值涨3亿港元
港股异动 | 郎生医药(00503)暴涨40% 私有化计划获计划股东批准 预期于12月19日撤销上市地位
智通财经 · 2023-11-28
港股异动 | 郎生医药(00503)暴涨40% 私有化计划获计划股东批准 预期于12月19日撤销上市地位
朗生医药(00503)反弹40% 私有化议案获通过
凤凰网港股 · 2023-11-28
朗生医药(00503)反弹40% 私有化议案获通过
智通港股早知道 | 民营房企融资再获大力支持 碳酸锂期价创新低
智通财经 · 2023-11-28
智通港股早知道 | 民营房企融资再获大力支持 碳酸锂期价创新低
朗生医药(00503):私有化计划获计划股东批准 预期将于12月19日撤销上市地位
智通财经 · 2023-11-27
朗生医药(00503):私有化计划获计划股东批准 预期将于12月19日撤销上市地位
朗生医药(00503)下跌20.0%,报1.4元/股
金融界 · 2023-11-27
朗生医药(00503)下跌20.0%,报1.4元/股
朗生医药盘中异动 大幅下挫5.14%报1.660港元
自选股智能写手 · 2023-11-27
朗生医药盘中异动 大幅下挫5.14%报1.660港元
加载更多
公司概况
公司名称:
朗生医药
所属市场:
SEHK
上市日期:
--
主营业务:
朗生医药控股有限公司是一家主要从事医药业务的香港投资控股公司。该公司通过三大分部运营。专科药品分部从事风湿及皮肤科领域专科药品的开发、生产及销售。其核心专科药品包括帕夫林、来氟米特片及吗替麦考酚酯分散片。植物提取及保健产品分部从事中药提取物及保健产品的开发、生产及销售。其他药品分部从事其他药品相关业务。
发行价格:
--
{"stockData":{"symbol":"00503","market":"HK","secType":"STK","nameCN":"朗生医药","latestPrice":1.79,"timestamp":1702862411158,"preClose":1.79,"halted":3,"volume":0,"delay":0,"floatShares":419328434,"shares":419328434,"eps":0.1600047,"marketStatus":"停牌","marketStatusCode":7,"change":0,"latestTime":"12-18 09:20:11","open":1.79,"high":1.79,"low":1.79,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.13610306210353199,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1713749400000},"adr":0,"adjPreClose":1.79,"dividendRate":0.027006,"openAndCloseTimeList":[[1713490200000,1713499200000],[1713502800000,1713513600000]],"volumeRatio":0,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/00503","defaultTab":"news","newsList":[{"id":"2392581933","title":"朗生医药:预期将于12月19日撤销上市地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2392581933","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2392581933?lang=zh_cn&edition=full","pubTime":"2023-12-18 09:15","pubTimestamp":1702862121,"startTime":"0","endTime":"0","summary":"朗生医药及要约人国泰国际医药生产及销售(中国)有限公司联合公布,该计划于2023年12月14日举行的聆讯上在没有修改的情况下获得批准。批准计划的大法院命令(批准令)副本已于2023年12月15日送交开曼群岛公司注册处处长登记。计划文件第四部分说明备忘录“建议-该建议之条件”一节所载的所有条件均已达成,该计划已于2023年12月15日生效。 撤销股份于联交所主板的上市地位,预期自2023年12月19日(星期二)上午9时正起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-18/doc-imzykuwe4200491.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-18/doc-imzykuwe4200491.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2392980186","title":"朗生医药(00503):预期将于12月19日撤销上市地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2392980186","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2392980186?lang=zh_cn&edition=full","pubTime":"2023-12-18 08:27","pubTimestamp":1702859256,"startTime":"0","endTime":"0","summary":"智通财经APP讯,朗生医药 及要约人国泰国际医药生产及销售(中国)有限公司联合公布,该计划于2023年12月14日举行的聆讯上在没有修改的情况下获得批准。批准计划的大法院命令(批准令)副本已于2023年12月15日送交开曼群岛公司注册处处长登记。计划文件第四部分说明备忘录“建议-该建议之条件”一节所载的所有条件均已达成,该计划已于2023年12月15日生效。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1039057.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2391680196","title":"朗生医药将于12月19日起被撤销股份于联交所主板的上市地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2391680196","media":"新浪港股","top":-1,"share":"https://www.laohu8.com/m/news/2391680196?lang=zh_cn&edition=full","pubTime":"2023-12-15 08:31","pubTimestamp":1702600306,"startTime":"0","endTime":"0","summary":"朗生医药(00503)公布,联交所已批准撤销股份于联交所主板的上市地位,自2023年12月19日(星期二)上午九时正(香港时间)起生效,惟须待该计划生效后方可作实。\n\n股市回暖,抄底炒股先开户!智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-15/doc-imzxzxmi5044752.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2023-12-15/doc-imzxzxmi5044752.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2391368291","title":"朗生医药(00503)将于12月19日起被撤销股份于联交所主板的上市地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2391368291","media":"智通财经网","top":-1,"share":"https://www.laohu8.com/m/news/2391368291?lang=zh_cn&edition=full","pubTime":"2023-12-15 07:36","pubTimestamp":1702596965,"startTime":"0","endTime":"0","summary":"智通财经APP讯,朗生医药(00503)公布,联交所已批准撤销股份于联交所主板的上市地位,自2023年12月19日(星期二)上午九时正(香港时间)起生效,惟须待该计划生效后方可作实。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121507390583fa6c25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2023121507390583fa6c25&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2386197304","title":"港股收盘(11.28) | 恒指收跌0.98% 苹果概念股逆势走强 瑞声科技(02018)收涨逾7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2386197304","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2386197304?lang=zh_cn&edition=full","pubTime":"2023-11-28 16:38","pubTimestamp":1701160717,"startTime":"0","endTime":"0","summary":"截止收盘,恒生指数跌0.98%或170.92点,报17354.14点,全日成交额950.09亿港元;恒生国企指数跌1.13%,报5957.08点;恒生科技指数跌0.77%,报4000.42点。截至收盘,涨4.75%,报75.05港元,成交额10.94亿港元,贡献恒指3.91点。截至收盘,瑞声科技涨7.54%,报22.1港元;丘钛科技涨7.19%,报4.92港元;舜宇光学科技涨4.75%,报75.05港元;高伟电子涨3.99%,报20.85港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1030175.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2386165818","title":"朗生医药股价拉升40.16% 市值涨3亿港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2386165818","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2386165818?lang=zh_cn&edition=full","pubTime":"2023-11-28 09:35","pubTimestamp":1701135317,"startTime":"0","endTime":"0","summary":"2023年11月28日早盘09时35分,朗生医药股票出现波动,股价急速拉升40.16%。朗生医药股票所在的药品行业中,整体涨幅为0.02%。其相关个股中,朗生医药、赛生药业、泰凌医药涨幅较大,振幅较大的相关个股有朗生医药、赛生药业、开拓药业-B,振幅分别为25.98%、3.34%、3.03%。消息层面,截至09时35分,《朗生医药:私有化计划获计划股东批准 预期将于12月19日撤销上市地位》资讯为影响朗生医药的重要信息。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231128093518806afdac&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20231128093518806afdac&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2386636071","title":"港股异动 | 郎生医药(00503)暴涨40% 私有化计划获计划股东批准 预期于12月19日撤销上市地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2386636071","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2386636071?lang=zh_cn&edition=full","pubTime":"2023-11-28 09:32","pubTimestamp":1701135167,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,朗生医药(00503)开盘后暴涨40%。截至发稿,涨40.16%,报1.78港元,成交额301.46万港元。消息面上,郎生医药及要约人国泰国际医药生产及销售(中国)有限公司联合公布,于2023年11月27日(星期一),批准该计划的决议案已于法院会议上获计划股东批准。公告称,预期股份将于2023年11月28日(星期二)下午4时10分后于联交所停止买卖,待该计划生效后,预期股份于联交所撤销上市地位将自2023年12月19日(星期二)上午九时正起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1029960.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2386216363","title":"朗生医药(00503)反弹40% 私有化议案获通过","url":"https://stock-news.laohu8.com/highlight/detail?id=2386216363","media":"凤凰网港股","top":-1,"share":"https://www.laohu8.com/m/news/2386216363?lang=zh_cn&edition=full","pubTime":"2023-11-28 09:32","pubTimestamp":1701135161,"startTime":"0","endTime":"0","summary":"金吾财讯 | 朗生医药(00503)反弹近40%,报1.78港元。值得注意的是,该股昨日暴跌近30%。朗生医药公布,私有化议案获法院会议及股东大会通过。预期股份将于11月28日(周二)下午4时10分后于联交所停止买卖,待该计划生效后,预期股份于联交所撤销上市地位将自12月19日上午9时正起生效。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://hknews.szfuit.com/newRssInfo/feed?original_id=53eb58d0e4a712af0439e63475758eef","is_publish_highlight":false,"gpt_icon":0},{"id":"2386152443","title":"智通港股早知道 | 民营房企融资再获大力支持 碳酸锂期价创新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2386152443","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2386152443?lang=zh_cn&edition=full","pubTime":"2023-11-28 07:50","pubTimestamp":1701129021,"startTime":"0","endTime":"0","summary":"央行等八部门发文支持民营经济 民营房企被专门提及11月27日,央行等八部门重磅发文,印发《关于强化金融支持举措助力民营经济发展壮大的通知》,提出支持民营经济的25条具体举措。试点单位应在危险废物经营许可证有效期和核准经营规模内接受废铅蓄电池。试点工作自本通知印发之日起,至2025年12月31日结束。碳酸锂期价创新低 机构:未来或跌破10万大关在现货供需失衡、市场看空情绪笼罩下,碳酸锂期货再度跌停。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1029922.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2386895791","title":"朗生医药(00503):私有化计划获计划股东批准 预期将于12月19日撤销上市地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2386895791","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2386895791?lang=zh_cn&edition=full","pubTime":"2023-11-27 18:55","pubTimestamp":1701082518,"startTime":"0","endTime":"0","summary":"智通财经APP讯,朗生医药(00503)及要约人国泰国际医药生产及销售(中国)有限公司联合公布,于2023年11月27日(星期一),批准该计划的决议案已于法院会议上获计划股东批准。预期股份将于2023年11月28日(星期二)下午4时10分后于联交所停止买卖,待该计划生效后,预期股份于联交所撤销上市地位将自2023年12月19日(星期二)上午九时正起生效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1029755.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2386845909","title":"朗生医药(00503)下跌20.0%,报1.4元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2386845909","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2386845909?lang=zh_cn&edition=full","pubTime":"2023-11-27 14:53","pubTimestamp":1701067983,"startTime":"0","endTime":"0","summary":"11月27日,朗生医药(00503)盘中下跌20.0%,截至14:53,报1.4元/股,成交104.95万元。朗生医药控股有限公司主要从事中药及化学药品的研发、生产及销售,涉及风湿科、皮肤科、医学美容、植物提取等领域,拥有两处现代化生产厂房和8条生产线,近70个产品生产批文。公司主推产品白芍总苷胶囊(帕夫林)已成为国内风湿免疫领域的大品种药物,并已建立了以宁波为中心的全国医药营销网络。截至2023年中报,朗生医药营业总收入2.27亿元、净利润4055.12万元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2023/11/27145338588734.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2386906439","title":"朗生医药盘中异动 大幅下挫5.14%报1.660港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2386906439","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2386906439?lang=zh_cn&edition=full","pubTime":"2023-11-27 14:43","pubTimestamp":1701067432,"startTime":"0","endTime":"0","summary":"2023年11月27日下午盘14时43分,朗生医药股票出现波动,股价急速下跌5.14%。截至发稿,该股报1.660港元/股,成交量43.5778万股,换手率0.10%,振幅5.71%。资金方面,该股资金流入13.348万港元,流出50.319万港元。朗生医药股票所在的药品行业中,整体涨幅为0.03%。其相关个股中,泰凌医药、中智药业、赛生药业涨幅较大,振幅较大的相关个股有开拓药业-B、中智药业、赛生药业,振幅分别为25.96%、9.09%、7.25%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311271443528308ae05&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202311271443528308ae05&s=b","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.lansen.com.cn","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0.0719},{"period":"1year","weight":0.226},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":-0.0298},{"period":"1month","weight":-0.0193},{"period":"3month","weight":0.0598},{"period":"6month","weight":-0.0552},{"period":"1year","weight":-0.2046},{"period":"ytd","weight":-0.0483}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"朗生医药控股有限公司是一家主要从事医药业务的香港投资控股公司。该公司通过三大分部运营。专科药品分部从事风湿及皮肤科领域专科药品的开发、生产及销售。其核心专科药品包括帕夫林、来氟米特片及吗替麦考酚酯分散片。植物提取及保健产品分部从事中药提取物及保健产品的开发、生产及销售。其他药品分部从事其他药品相关业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.153846,"avgChangeRate":-0.045295},{"month":2,"riseRate":0.538462,"avgChangeRate":0.026958},{"month":3,"riseRate":0.384615,"avgChangeRate":-0.035309},{"month":4,"riseRate":0.692308,"avgChangeRate":0.068768},{"month":5,"riseRate":0.461538,"avgChangeRate":0.001494},{"month":6,"riseRate":0.714286,"avgChangeRate":0.063303},{"month":7,"riseRate":0.357143,"avgChangeRate":-0.037397},{"month":8,"riseRate":0.428571,"avgChangeRate":-0.051738},{"month":9,"riseRate":0.5,"avgChangeRate":0.017982},{"month":10,"riseRate":0.642857,"avgChangeRate":0.048119},{"month":11,"riseRate":0.428571,"avgChangeRate":0.021742},{"month":12,"riseRate":0.357143,"avgChangeRate":0.076821}],"exchange":"SEHK","name":"朗生医药","nameEN":"LANSEN PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"朗生医药(00503)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供朗生医药(00503)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"朗生医药,00503,朗生医药股票,朗生医药股票老虎,朗生医药股票老虎国际,朗生医药行情,朗生医药股票行情,朗生医药股价,朗生医药股市,朗生医药股票价格,朗生医药股票交易,朗生医药股票购买,朗生医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"朗生医药(00503)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供朗生医药(00503)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}